FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES Stock

Certificat

DE000ME4U8A6

Real-time Bid/Ask 11:03:28 2024-05-28 EDT
8.34 EUR / 8.42 EUR -19.58% Intraday chart for FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES
Current month+29.12%
1 month+26.46%
Date Price Change
24-05-28 10.37 -0.48%
24-05-27 10.42 -2.07%
24-05-24 10.64 +0.95%
24-05-23 10.54 -11.43%
24-05-22 11.9 -2.70%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 06:05 am

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN ME4U8A
ISINDE000ME4U8A6
Date issued 2023-12-06
Strike 79.09 $
Maturity Unlimited
Parity 1.39 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 21.8
Lowest since issue 7.68
Spread 0.11
Spread %1.21%

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
94.89 USD
Average target price
107.9 USD
Spread / Average Target
+13.70%
Consensus